KRISTINA LEPARD: Open Payments
NPI 1053020362 · VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 11 payments from 8 companies in 2025. Trend: 2023 $514 · 2024 $403 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $168 |
| Gilead Sciences, Inc. | 2 | $154 |
| GENZYME CORPORATION | 1 | $50 |
| ABBVIE INC. | 1 | $31 |
| Lilly USA, LLC | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $19 |
| Philips North America LLC | 1 | $15 |
Products named: BREZTRI, DUPIXENT, AIRSUPRA, UBRELVY, MOUNJARO, SHINGRIX, APTIMA, Diagnostic ECG Service.
Industry payments across CA — which companies pay providers there.
